Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide nasal irrigation versus budesonide nasal spray in chronic rhinosinusitis without prior surgery
RBR-7qt7vkRecruiting
- Sponsor
- Federal University of São Paulo
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of budesonide in chronic rhinosinusitis (CRS) (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Not reported. Started Apr 2020; status: recruiting.
02
Drugs
budesonide
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on RBR-7qt7vk.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-7qt7vk.